Labomar S p A : Investor Access Event – Parigi_04.04.2023_Presentazione

LABOMAR

Investor Access Event

Paris, April 4th, 2023

TODAY SPEAKERS

WALTER BERTIN

Founder & CEO

Founded Labomar in 1998 from the "Farmacia Bertin"

Member of Assindustria Veneto Centro since 2012

Graduated in pharmaceutical science and completed a Master degree in Lean Mangement

CLAUDIO DE NADAI

IR & Board Director

Consultant for Labomar since 2007 on financial strategy and Board Member since 2018, he led the asset deal of ImportFab and Welcare

After 13 yars as CFO and General Manager of an Italian SME and a past entrepreneurial experience in agri-food, he founded BModel (corporate finance boutique)

NICOLA TOMASINI

CFO

Joined Labomar Group at the end of 2022 and appointed as CFO

Professionally matured in Audit and International M&A roles at PwC, has further developed 10 years of experience as Business & Financial Controller and CFO in listed and PE backed companies.

FRANCESCO DA RIVA

Head of Sales

Significant experience in Labomar, first as Head of Foreign Sales and since the beginning of 2020 as Head of Sales and Commercial Networks

Extensive previous experience as Senior Consultant in Strategy and Business Planning

Education: MiMAC 1 (SDA Bocconi School

of Management) EMBA 16 (CUOA Business

School)

AGENDA

1

2

3

Heritage,

Vision & Mission,

Sustainability

Labomar

Stand Alone

Labomar Business Model Evolution

4	2022 FY Results
and 2023 Guidance

5	Focus Single
Controlled Companies

3

AGENDA

1

2

3

Heritage,

Vision & Mission,

Sustainability

Labomar

Stand Alone

Labomar Business

Model Evolution

4	2022 FY Results
and 2023 Guidance

5	Focus Single
Controlled Companies

4

HERITAGE

Foundation of

LABOMAR RESEARCH,

the R&D Branch of Labomar; the company starts building its reserach-driven DNA

1998

2004

Labomar starts building a committed qualified management team

2011

Fondo Italiano d'Investimento invests in Labomar's equity

2015

Since 2016 Start of the Lean Transformation process

2018

November, acquisition

of Importfab,

Canada-based Pharma

CMO

Equity investment

(5%) in Project Zero srl, devolping vertical farming techniques for vegetal extracts

Establishment of

Herbae srl

(now Labomar Next srl)

2021

July

Acquisition of the majority of Welcare Research srl, Italian company specialized in wound healing medical devices

September

Set up of Labovar srl, a commercial company that will sell online in the Chinese market

Acquisition of the 17,6% of

Labiotre srl. With this partecipation, 2022 Labomar owns 48,8% of

Labiotre srl.

2003

Foundation of LABOMAR from the pharmacy of Dr. Bertin

Source: Management

2008

Labomar begins its transformation from pharmaceutical lab to industrial manufacturing company

2012

Foundation of Labiotre s.r.l., to guarantee the highest possible quality of raw materials

Attainment of the GMP and ISO9001 certifications

2016

Roll-off of the brand-new, pharmagrade standard L3 plant

2019					November
				Labomar owns 100% of Labiotre srl
		2020
			December
					Labomar exercises call option and
					acquires an additional 7% of
					Welcare Research srl, increasing
					its stake to 70%

	August
Juanuary	Statue Change
Dr Bertin buys back	October
minorities and owns 100%	Listing on Milan
of Labomar	stock exchange

Double digit growth thanks to integration.

Start of the construction process of logistic hub L6.

5